Compare ATXS & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATXS | CGNT |
|---|---|---|
| Founded | 2008 | 2020 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.4M | 704.1M |
| IPO Year | 2015 | N/A |
| Metric | ATXS | CGNT |
|---|---|---|
| Price | $12.58 | $9.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $24.33 | $14.00 |
| AVG Volume (30 Days) | ★ 793.4K | 237.0K |
| Earning Date | 03-10-2026 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $706,000.00 | ★ $388,304,000.00 |
| Revenue This Year | N/A | $16.36 |
| Revenue Next Year | N/A | $10.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.27 |
| 52 Week Low | $3.56 | $7.64 |
| 52 Week High | $13.29 | $11.66 |
| Indicator | ATXS | CGNT |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 50.91 |
| Support Level | $12.24 | $8.87 |
| Resistance Level | $12.86 | $9.10 |
| Average True Range (ATR) | 0.25 | 0.27 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 32.54 | 40.95 |
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.